Glucose Deprivation Induces G2/M Transition-Arrest and Cell Death in N-GlcNAc2-Modified Protein-Producing Renal Carcinoma Cells

Abstract

Some cancer cells can survive under glucose deprivation within the microenvironment of a tumor. Recently, we reported that N-linked (β-N-acetylglucosamine)2 [N-GlcNAc2]-modified proteins induce G2/M arrest and cell death under glucose deprivation. Here, we investigated whether such a response to glucose deprivation contributes to the survival of renal cell carcinomas, which are sensitive to nutritional stress. Specifically, we analyzed seven renal carcinoma cell lines. Four of these cell lines produced N-GlcNAc2-modified proteins and led G2/M-phase arrest under glucose deprivation, leading to cell death. The remaining three cell lines did not produce N-GlcNAc2-modified proteins and undergo G1/S-phase arrest under glucose deprivation, leading to survival. The four dead cell lines displayed significant up-regulation in the UDP-GlcNAc biosynthesis pathway as well as increased phosphorylation of p53, which was not observed in the surviving three cell lines. In addition, the four dead cell lines showed prolonged up-regulated expression of ATF3, which is related to unfolded protein response (UPR), while the surviving three cell lines showed only transient up-regulation of ATF3. In this study, we demonstrated that the renal carcinoma cells which accumulate N-GlcNAc2-modified proteins under glucose deprivation do not survive with abnormaly prolonged UPR pathway. By contrast, renal carcinoma cells that do not accumulate N-GlcNAc2-modified proteins under these conditions survive. Morover, we demonstrated that buformin, a UPR inhibitor, efficiently reduced cell survival under conditions of glucose deprivation for both sensitive and resistant phenotypes. Further studies to clarify these findings will lead to the development of novel chemotherapeutic treatments for renal cancer.

Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling

“…Recent in vitro and in vivo studies have shown that there are differential responses of cancer cells to glucose deprivation under different genetic and epigenetic background, indicating that metabolic profiles of tumors are likely dependent on both the genotype and tissue of origin [17, 18]. The restriction of glucose induced G1 phase arrest and apoptosis in breast, leukemia, prostate and lung cancer cells[15, 18–21], while N-GlcNAc2-modified protein-producing renal carcinoma and bladder cancer cells arrested in G2/M-phase alone, with the changes triggered by glucose deprivation[22, 23]. In this study, we examined the changes in cell cycle and apoptosis in two endometrial cancer cell lines treated with different concentrations of glucose.…”

Integrated omics-analysis reveals Wnt-mediated NAD+ metabolic reprogramming in cancer stem-like cells

“…Some cancer cells increase their survival capacity under conditions of glucose deprivation [15, 16] by circumventing apoptotic signals. Indeed, CSCs displayed remarkably higher viability than did non-CSCs, which rapidly underwent apoptotic cell death in glucose deprivation [14] (Figure S1).…”

A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma

“…However, cancer cells expressing highly SOD2 can survive in a nutritionally-depleted environment via preserving mitochondrial function and preventing ROS accumulation [22]. This helps to maintain the dormant character in RCC development [8,9]. It has been previously demonstrated that inhibitors targeting mitochondrial oxidative phosphorylation such as biguanides induce death of RCC cells and may become therapeutic options to overcome the disastrous consequences of SOD2abundance in RCC cells [9].…”